✦ LIBER ✦

Effects of intensive poisoning of dogs with botulinum toxin—Type A

✍ Scribed by George G. Armstrong; John J. Gilluly; Arthur C. Guyton

Book ID: 115674094
Publisher: Elsevier Science
Year: 1954
Tongue: English
Weight: 246 KB
Volume: 16
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(54)90402-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neurophysiological effects of botulinum

Neurophysiological effects of botulinum toxin type a

✍ G. Abbruzzese; A. Berardelli 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 806 KB

Clinical use of non-a botulinum toxins:

Clinical use of non-a botulinum toxins: Botulinum toxin type C and botulinum toxin type F

✍ Roberto Eleopra; Valeria Tugnoli; Rocco Quatrale; Ornella Rossetto; Cesare Monte 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 850 KB

Clinical use of non-a botulinum toxins:

Clinical use of non-a botulinum toxins: botulinum toxin type B

✍ Dirk Dressler; Roberto Eleopra 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 977 KB

Complications of Botulinum Toxin Type A

✍ Carruthers, Jean; Carruthers, Alastair 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 287 KB

Botulinum toxin antibody type A titres a

Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy

✍ Dirk Dressler; Hans Bigalke 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

## Abstract In some patients, therapy with botulinum toxin type A (BT‐A) becomes ineffective due to formation of antibodies (BT‐A‐AB). The time course of BT‐A‐AB titres after cessation of BT‐A therapy was quantitatively studied to determine whether and when they might drop. Thirteen patients (eight

Central effects of botulinum toxin type

Central effects of botulinum toxin type A: Evidence and supposition

✍ Antonio Currà; Carlo Trompetto; Giovanni Abbruzzese; Alfredo Berardelli 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

No convincing evidence exists that botulinum toxin type A (BT-A) injected intramuscularly at therapeutic doses in humans acts directly on central nervous system (CNS) structures. Nevertheless, several studies, using various approaches, strongly suggest that BT-A affects the functional organization o